133 results
Page 3 of 7
8-K
EX-99.1
u57e7ve2x
10 Oct 23
Patent Application Filed with Potential to Extend AmeluzĀ® Protection to 2043
9:15am
8-K
EX-99.1
rnw8d
4 Oct 23
Biofrontera Inc. Announces Preliminary Third Quarter Revenues
8:45am
8-K
EX-99.1
2i4bnyf 99yjr3hi
3 Oct 23
Other Events
5:17pm
8-K
EX-99.2
lbfde8i ea9a8fbj0
3 Oct 23
Other Events
5:17pm
8-K
EX-99.1
pfj68b vdxphdng
11 Aug 23
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
7:30am
8-K
EX-99.1
upljfonvdjngni
13 Jul 23
Management Reaffirms Full-Year 2023 Revenue Growth of at least 25% over Prior Year
12:00am
8-K
EX-99.1
jw920y555y6mr6cdjsal
12 Jul 23
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of Directors
8:44am
8-K
EX-99.1
8diyx3f1sr1hkd
3 Jul 23
Biofrontera Inc. Announces 1-for-20 Reverse Stock Split
9:25am
8-K
EX-99.1
np1at4ocjkwnd9vx4qwn
1 Jun 23
Biofrontera Inc. Begins Development of a Portable Photodynamic Therapy Lamp for Use with AmeluzĀ®-PDT
9:15am
8-K
EX-99.1
s8um4
30 May 23
Biofrontera Inc. Names Founder and Executive Chairman Hermann
9:00am
8-K
sf7ijquxnil1 547a
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:12pm
8-K
EX-99.2
hjpo5ur9tvc
12 May 23
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
8:09am
8-K
EX-99.1
44r0nhoo i6c
12 May 23
Biofrontera Inc. Reports First Quarter 2023 Financial Results and Provides a Business Update
8:09am
8-K
EX-10.1
cuycj8c oxg4f
16 Dec 22
Departure of Directors or Certain Officers
8:00am
DEFA14A
dsgii
21 Nov 22
Additional proxy soliciting materials
5:20pm
424B3
hnmdwvmwgid3
15 Nov 22
Prospectus supplement
5:28pm